Charles Z. Ding,Shuhui Chen,Baoping Zhao,Xile Liu,Linxia Xiao,Chao Ding,Fei Wang,Jian Li
申请号:
US15570627
公开号:
US10494373B2
申请日:
2016.04.20
申请国别(地区):
US
年份:
2019
代理人:
摘要:
Disclosed is a fused-ring or tricyclic aryl pyrimidine compound used as a mutation selectivity EGFR inhibitor. Specifically, disclosed is a compound represented by formula (I) and used as an EGFR inhibitor or a pharmaceutically acceptable salt thereof.